Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
10/2008
10/16/2008WO2008057862A3 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
10/16/2008US20080255196 Pesticide Thiazolyloxy Substituted Phenylamidine Derivatives
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255123 (2Z)-2-(3-butyl-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene)-1-(5-chloro-2-methoxyphenyl)ethanone; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants
10/16/2008US20080255101 spiro[2H-1,2,4-benzothiadiazine-3,4'-piperidin]-1'-yloxy,7-(aminosulfonyl)-6-chloro-2',2',6',6'-tetramethyl-1,1-dioxide; antidiabetic agent; electrolyte retention; cardiovascular diseases; renovascular diseases; oxidative stress; endothelial dysfunctions; endothelial dysfunctions; cirrhosis; osteoporosis
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008CN101284820A Amino peptidase inhibiting substance and synthetic method
10/14/2008CA2330359C Reduction of postoperative complications of cardiopulmonary bypass (cpb) surgery
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/14/2008CA2254610C A process for making 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole using methyldithiocarbazinate with trifluoroacetic acid with selective removal of 2,5-bis(methylthio)-1,3,4-thiadiazole
10/09/2008WO2008120093A1 Sulfonamides and pharmaceutical compositions thereof
10/09/2008US20080249094 Compounds for the treatment of neurodegenerative disorders
10/09/2008US20080249093 immunosuppressive, anti-inflammatory and hemostatic agents to modulate leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity; safer and more effective; 3-(4-(5-(3-Cyano-4-isopropyloxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoic acid
10/09/2008US20080249080 Benzodiazepine Derivatives and Uses Thereof on Medical Field
10/09/2008US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide
10/08/2008CN101282952A Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/08/2008CN101282951A N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/08/2008CN101279956A Matrix metalloprotease inhibitors and synthetic method thereof
10/07/2008US7432292 Anticancer agents; autoimmune diseases; antiinflammatory agents; ; graft versus host disease; Crohn's diseases; skin disorders
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008CA2330256C Treatment of inflammatory bowel disease
10/03/2008WO2008128639A1 Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide
10/02/2008WO2008116302A1 Cathepsin cysteine protease inhibitors
10/02/2008WO2008073958A3 Substituted benzothiadiazinedioxide derivatives and methods of their use
10/02/2008US20080242860 Silver halide color photographic light-sensitive material and image formation method using the same, silver halide emulsion, reducing compound having group adsorptive to silver halide and method for producing the same
10/02/2008US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
10/02/2008US20080241949 Halogenating dibenzo[b,f][1,4]thiazepine 11-(10H) compound; slurrying
10/01/2008EP1973890A2 Indane modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
10/01/2008EP1973887A1 Aza heterocyclics for the treatment of malaria or aids
10/01/2008EP1973872A1 Inhibitors of histone deacetylase and prodrugs thereof
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008CN101277941A Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake
10/01/2008CN101277940A 4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/01/2008CN101274921A Synthetic method for taurolidine and pharmaceutical preparations
10/01/2008CN100422164C Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
09/2008
09/30/2008CA2355470C Benzoheterocycles and their use as mek inhibitors
09/25/2008US20080234273 Such as 3-{[4-(azetidin-1-ylcarbonyl)-2-chlorophenyl]oxy}-5-({(1S)-2-[(difluoromethyl)oxy]-1-methylethyl}oxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinases (Glk)
09/24/2008EP1971583A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
09/24/2008CN101273048A Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
09/24/2008CN100420686C New [1,2,3]-thiobiazole derivative and its synthesis and use
09/23/2008US7427621 neurodegenerative diseases: Alzheimer's disease; amyloid plague
09/18/2008WO2008111588A1 Method for producing difluoromethanebis(sulfonylfluoride)
09/18/2008WO2008111473A1 Glucokinase activator
09/18/2008WO2008110278A2 Use of n2-phenylamidines as herbicides and herbicidal agents comprising the same
09/18/2008US20080227961 Chelation compounds, radionuclides
09/18/2008US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease
09/18/2008CA2680617A1 Use of n2-phenylamidines as herbicides
09/18/2008CA2679971A1 Glucokinase activator
09/17/2008EP1968963A1 Substituted propiolic acid amides and their use for producing analgesics
09/17/2008EP1392639B1 Pyruvate derivatives
09/17/2008CN101265241A Method for preventing and curing plant disease by increasing plant immunity and use thereof
09/17/2008CN101265240A Method for preventing and curing plant disease by increasing plant immunity and use thereof
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/16/2008US7425636 2-amino-5phenyl-(1,3,4)thiodiazoline derivatives; antitumor, anticarcinogenic agent; transcription factor STAT6 and integrin antagonist; breast, gastric, ovarian, colon, lung, brain, hematological, urinary or genital, bladder, prostatic, renal, pancreatic, uterine cancers, skin, hepatic carcinoma
09/16/2008US7425631 Compounds and methods of use
09/16/2008CA2182228C Codrugs as a method of controlled drug delivery
09/10/2008EP1965644A1 Novel herbicides
09/10/2008CN101263131A Urea glucokinase activators
09/10/2008CN101263129A Pesticide thiazolyloxy substituted phenylamidine derivatives
09/10/2008CN101260091A Acrylamides compounds containing 1,2,3-thiadiazoles ring and having anti-hepatitis B virus activity
09/09/2008US7423034 Benzothiazine and benzothiadiazine compounds
09/04/2008WO2008105607A1 Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonists
09/04/2008US20080214528 e.g. N-[3-{1-[(cyclobutyl)amino]-4-hydroxy-2-oxo-1,2-dihydro-quinolin -3-yl}-1,1-dioxo-1,4-dihydro-1 lambda 6-thieno[2,3-e][1,2,4]thiadiazin-7-yl)methyl]methane-sulfonamide; viricides for infections caused by an RNA-containing virus; hepatitis C virus (HCV) polymerase inhibitor; liver cirrhosis
09/04/2008US20080214448 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
09/04/2008CA2679185A1 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
09/03/2008EP1963295A1 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazine derivatives
09/03/2008EP1963294A1 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (ptpase)
09/03/2008EP1963293A1 1-orthofluorophenyl substituted 1, 2 , 5-thiazolidinedione derivatives as ptp-as inhibitors
09/03/2008EP1963292A2 Organic compounds
09/03/2008EP1704143B1 Malononitrile compound as pesticides
09/02/2008US7420001 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
08/2008
08/28/2008WO2008102908A1 Haloalkylsulfonanilide derivative
08/28/2008WO2008102348A1 Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof
08/28/2008WO2008101665A1 Macrocyclic compounds as hcv ns3 protease inhibitors
08/28/2008WO2008005764A3 Novel zeta-cypermethrin composition
08/28/2008US20080207706 Thiadiazoline derivative
08/28/2008US20080207703 Antibacterial heterocyclic ureas
08/28/2008US20080207701 Opioid receptor antagonists
08/28/2008US20080207636 Using a benzmide compound; antidiabetic agents; obesity
08/28/2008CA2677843A1 Macrocyclic compounds as hcv ns3 protease inhibitors
08/27/2008EP1960377A1 l , l , 3-TRI0X0-l , 2 , 5-THIADIAZ0LIDINES AND THEIR USE AS PTP-ASES INHIBITORS
08/27/2008EP1960343A2 Indene derivatives, their preparation and use as medicaments
08/27/2008EP1694659B1 Thiadiazoles as cxc- and cc- chemokine receptor ligands
08/27/2008CN101250168A Thiadiazoles imine derivative as well as synthesis and uses thereof
08/27/2008CN101250167A Heterocyclic compounds containing thiadiazole as well as synthesis and uses thereof
08/27/2008CN101250166A Thiadiazoles formamide derivative as well as synthesis and uses thereof
08/27/2008CN100413972C Enzymatic catalyzing process for the preparation of substituted 2-amino-3-(2-amino-phenylsulfanyl)-propionic acid
08/21/2008WO2008045558A3 Benzothiadiazine compounds and their use
08/21/2008US20080200457 4-Cyclopropyl-1,2,3,-Thiadiazole Compound, Agrohorticultural Plant Disease Controlling Agent And Method Of Using The Same
08/21/2008US20080200371 Thiazole and thiadiazole inhibitors of tyrosine phosphatases
08/20/2008EP1249233B1 Npyy5 antagonists
08/19/2008US7414142 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators
08/14/2008US20080194878 2,7-Di(4,4,5,5-tetramethyl-1,3,2-dioxa-borolan-2-yl)-9,9'-bis(4-methoxymethyloxyphenyl)-9H-fluorene, for example; can be utilized as hole transport materials, hole injection materials or the like of organic electroluminescence devices, electrophotographic receptors
08/14/2008US20080194654 Using monoamine oxidase inhibitor; prevention, therapy of gastrointestinal disorders; sexual disorders; antidepressants; cognition activators; analgesics
08/14/2008US20080194653 Using a thiadiazole drug; anticancer agents
08/14/2008US20080193413 Anti-Infective Agents
08/13/2008CN100411230C Application of organic sulfide in positive electrode material of secondary Mg battery
08/13/2008CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 100